Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 36897253

Brentuximab vedotin after autologous transplantation in pediatric patients with relapsed/refractory Hodgkin lymphoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood Adv
Publication date
2023 Jul 11
First author
Forlenza CJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Forlenza CJ
      type
      Author
    2. name
      Rosenzweig J
      type
      Author
    3. name
      Mauguen A
      type
      Author
    4. name
      Buhtoiarov I
      type
      Author
    5. name
      Cuglievan B
      type
      Author
    6. name
      Dave H
      type
      Author
    7. name
      Deyell RJ
      type
      Author
    8. name
      Flerlage JE
      type
      Author
    9. name
      Franklin AK
      type
      Author
    10. name
      Krajewski J
      type
      Author
    11. name
      Leger KJ
      type
      Author
    12. name
      Marks LJ
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Forlenza CJ
      type
      Author
    2. name
      Rosenzweig J
      type
      Author
    3. name
      Mauguen A
      type
      Author
    4. name
      Buhtoiarov I
      type
      Author
    5. name
      Cuglievan B
      type
      Author
    6. name
      Dave H
      type
      Author
    7. name
      Deyell RJ
      type
      Author
    8. name
      Flerlage JE
      type
      Author
    9. name
      Franklin AK
      type
      Author
    10. name
      Krajewski J
      type
      Author
    11. name
      Leger KJ
      type
      Author
    12. name
      Marks LJ
      type
      Author
    bibliography ids
    1. nci-bib-2ac92fafb16a77ba04e843fe
    book metadata
    content sha256
    69be89cc55a35adfe62b8f0e12c84000545f6992454406740fe891bfd40e4143
    document type
    citation
    dois
    1. 10.1182/bloodadvances.2022009323
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:36897253
    immutable id
    pubmed:36897253@69be89cc55a35adfe62b8f0e12c84000545f6992454406740fe891bfd40e4143
    journal
    abbreviation
    Blood Adv
    issn electronic
    2473-9537
    issn print
    2473-9529
    issue
    13
    name
    Blood advances
    nlm unique id
    101698425
    pages
    3225-3231
    volume
    7
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      36897253
      provenance
      batch id
      5329a5d0877ee70ecd11
      provider
      NCBI PubMed ESummary
      record sha256
      03391e68bfaec22d5a8b0319049be98a516c0bb8fc54fc6f08820e0413eed4dd
      response sha256
      bcc4d4935bae07b2d0bf7ef24187cf1ff9d849601f315c9dbe2002bd5de6f631
      retrieved at
      2026-09-09T23:48:15.763286+00:00
      publication date
      display
      2023 Jul 11
      precision
      day
      year
      2023
      publication types
      1. Journal Article
      2. Research Support, N.I.H., Extramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/36897253/
      title
      Brentuximab vedotin after autologous transplantation in pediatric patients with relapsed/refractory Hodgkin lymphoma.

      Preserved source evidence · Not medical advice